Founder and Managing Partner of the Pillar Group, a collection of investment funds established in 1991 focused on investing in innovative medical technologies and, more specifically, on drugs aimed at correcting the genetic causes of diseases. Pillar is currently a lead shareholder in U.S. companies committed to supporting research in genetics. In 2015, The Pillar Group established the Pillar Chair for Biomedical Research at the University of Massachusetts Medical Center. Pillar also established the Pillar Genetic Institute at the American University of Beirut Medical Centre.